Chemotherapy and breast cancer
The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.
... sporadic breast cancers and 70% of ovarian cancers ...Preclinical breast cancer studies suggest a role for BRCA1 in predicting response to DNA-damaging agents and taxane-based ...in ...
9
Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study.
... Neoadjuvant chemotherapy (NCT) administered prior to definitive surgical resection is rec- ommended as the standard of care in locally advanced breast ...stage breast cancer cases. It shrinks ...
13
Serum oxidative stress markers and genotoxic profile induced by chemotherapy in patients with breast cancer : a pilot study
... Population and Sample ...ductal breast cancer under treatment at the Department of Oncology, S˜ao Marcos Hos- pital, Teresina, Piau´ı, Brazil, from August 2012 to February ...to chemotherapy ...
12
The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy.
... studies, and this study was in compli- ance with the Helsinki ...All breast cancer patients provided written informed consent for their clinical data to be reviewed by ...2008 and March 2010, ...
5
Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors
... suppress cancer cells’ growth, proliferation, and survival in direct and indirect manners ...with chemotherapy in the treatment of patients with early operable and metastatic ...
6
A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
... with cancer progression and chemotherapy resistance via EMT process and CDCs regulation ...as cancer cell proliferation, invasion and drug resistance [39,40,41], but the exact ...
10
Intervention nurses in chemotherapy in women with breast cancer / Intervenção do enfermeiro no tratamento quimioterápico de mulheres com câncer de mama
... with breast cancer; unveiling behavioral changes in women undergoing mastectomy and chemotherapy; knowing the operational strategies of nurses in quality care on depression presented by ...
8
Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.
... miR-378c, and miR-18a were signifi- cantly associated with ER expression ...activity and stimulates tumor progression and ER positivity, which are consistent with our findings ...miR-422a and ...
22
WOMEN WITH BREAST CANCER UNDERWENT CHEMOTHERAPY: NURSING ASSISTANCE THROUGH A CONTEXTUAL ANALYSIS
... complications and toxicities produced by the use of chemotherapy in women with breast cancer and the nursing ...American and Caribbean Health Sciences (LILACS), Brazilian Nursing ...
9
Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study
... before breast cancer treatment, to exclude clinical neuropathy, we did not per- form quantitative sensory testing, and therefore, we cannot exclude the presence of subclinical deficits in sensory ...
11
Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.
... (ER-positive and/or PgR-positive, HER2- negative and Ki67 low ), luminal B (ER-positive and/or PgR- positive, HER2-negative and Ki67 high ), luminal-HER2 (ER- positive and/or ...
13
Experience of the spouse of a woman with breast cancer undergoing chemotherapy: a qualitative case study
... anthropology and utilizing an ethnographic case study ...interviews and participant ...suffering. Chemotherapy was seen as giving hope of healing the wife's ...treatment and subordinate to his ...
8
Interleukin18 is equally expressed in inflammatory breast cancer and locally advanced breast cancer : a possible association with chemotherapy response
... cells and arrowheads shows the marked IL-18 expression in stromal ...neoadjuvant chemotherapy response (P = 0.061; Table 2) was detected for both breast cancer subtypes IBC and ...
7
Depression and quality of life in patients with breast cancer undergoing chemotherapy and monoclonal antibodies
... symptoms and without depressive symptoms in the various scales of the QLQ- C30, QLQ-BR23 and the Hospital Anxiety and Depression Scale (HADS-D), the t-test was used, whenever both samples could be ...
20
Phytotherapy and nutritional supplements on breast cancer
... quinone and phe- nolic acid derivatives such as tanshinone (I, IIA, and IIB), cryptotanshinone, isocryptotanshinone, miltirone, tanshinol (I and II), and salviol ...agents and protect ...
43
THERAPEUTIC OPTIONS FOR BREAST CANCER
... underwent breast conserv- ing surgery, according to the scheme: 6 cycles of Docetaxel + Epirubicin in 14 cases, and FEC (5 Fluorouracil + Cyclophosphamide + Epirubicin), in 10 ...underwent breast ...
6
Left Ventricular Regional Wall Motion Abnormality is a Strong Predictor of Cardiotoxicity in Breast Cancer Patients Undergoing Chemotherapy
... with breast cancer and in chemotherapy treatment with potential cardiotoxicity medications including doxorubicin and ...during and after the treatment to assess the presence (or ...
7
Left Ventricular Regional Wall Motion Abnormality is a Strong Predictor of Cardiotoxicity in Breast Cancer Patients Undergoing Chemotherapy
... with breast cancer and in chemotherapy treatment with potential cardiotoxicity medications including doxorubicin and ...during and after the treatment to assess the presence (or ...
7
Anxiety and cognitive functioning in breast cancer patients treated with chemotherapy
... predisposition and vulnerability, psychosocial variables ...radiotherapy and hormone therapy) (Collins et ...involving breast cancer women revealed that anxiety may increase vulnerability to ...
13
Quality of life of women with breast cancer undergoing chemotherapy
... with breast cancer undergoing ...Research and Treatment of Cancer Core Quality of Life Questionnaire-30 and Supplementary Questionnaire Breast Cancer ...socio-demographic ...
8